Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Maternal Health

Women's_Health

Women’s Health Today—March 18, 2026

This biweekly Women’s Health update highlights regulatory momentum, late-stage…

Women's_Health

Women's Health Weekly News - April 30th 2025

Women's Health Breakthroughs: WHI Restored, Endometriosis Test, Ιmpact of…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—March 20, 2026
Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like receptor assets
Cardiovascular Today—March 19, 2026
Rare Diseases Today—March 19, 2026
Cell and Gene Therapy Today—March 19, 2026

Tags

AAV-based gene therapies adaptive design American Academy of Pediatrics American Society of Clinical Oncology Amulet 360 Autoimmune disease therapies cancer care Cancer drug development cancer vaccines clinicaltrials competitive advantage CVC Cytokine release syndrome datasecurity digital health innovation digital pill drug development Echocardiography monitoring EGFR-mutated non-small cell lung cancer EV148 fair pricing FDA gene therapy approvals FDA neuroscience approvals google ventures HeartFlow hepatitis D mental health Minimally invasive surgery Nanell Nipocalimab NMDA Obesity market trends Pain patient centricity Pulmonary hypertension–interstitial lung disease Rare disease drug pipeline Sapien M3 surgical robotics synergies Tecvayli US health crisis Vanscoy Rare Pharmacy Venous thromboembolism VOICE ASSISTANT Women’s health market trends

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—March 20, 2026
Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like receptor assets
Cardiovascular Today—March 19, 2026
Rare Diseases Today—March 19, 2026
Cell and Gene Therapy Today—March 19, 2026

TAGS

AAV-based gene therapies adaptive design American Academy of Pediatrics American Society of Clinical Oncology Amulet 360 Autoimmune disease therapies cancer care Cancer drug development cancer vaccines clinicaltrials competitive advantage CVC Cytokine release syndrome datasecurity digital health innovation digital pill drug development Echocardiography monitoring EGFR-mutated non-small cell lung cancer EV148 fair pricing FDA gene therapy approvals FDA neuroscience approvals google ventures HeartFlow hepatitis D mental health Minimally invasive surgery Nanell Nipocalimab NMDA Obesity market trends Pain patient centricity Pulmonary hypertension–interstitial lung disease Rare disease drug pipeline Sapien M3 surgical robotics synergies Tecvayli US health crisis Vanscoy Rare Pharmacy Venous thromboembolism VOICE ASSISTANT Women’s health market trends

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy